Rader: “The law makes no sense any more”

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Rader: “The law makes no sense any more”

Former Chief Judge of the Federal Circuit Randall Rader has said that recent Supreme Court decisions have left the United States so out of step with the rest of the world that legislative correction is needed

randall20rader20aipla.jpg

“The point is the law makes no sense any more, and when it makes no sense any more it has to be rewritten,” Rader said in an afternoon session on patent law yesterday at the AIPLA Annual Meeting. “Not in the House, but the Senate – the Republicans are coming!”

Rader said that he recently did something he had not done for a long time – he read a judicial opinion five times. It was the Australian Myriad judicial opinion.

“The Australian version of Myriad, not the American one, got it dead right,” said Rader. “United States law is the one that is out of tune.”

Rader appeared to suggest that the audience should consider how an appeal will affect the law before filing one. One audience member pushed him on this, saying a client may think settlement terms are unacceptable even if an appeal may change the law in a way it doesn’t like.

“What I’m telling you is if you bring Bilski to the Supreme Court you can expect the results you are going to get,” replied Rader.

“Therefore, if you are wise, you settle it before it gets there. Has that happened before? Yes. Dozens of times and that’s what this group can do strategically to get a good case so that there is good law.

“How well have you done with Bilski, Alice, Prometheus and Myriad? How do you propose we get from the US state of patent eligibility, which is out of step with the whole world, back in to harmony with international standards? I just told you – legislative correction.”

Rader said that given a case with the right characteristics, however, there is a chance for the law to be narrowed. “If you find the right case, there is room to narrow it,” he said.

bob20stoll20aipla.jpg

Responding to some pessimistic audience comments about the effect the Supreme Court is having on innovation in the technology space, Bob Stoll, the session’s moderator, said: “I do think software is patentable and claiming it in a manner that is viable is still possible. But I think there are significant problems and we need to figure out a way to make sure it doesn’t deteriorate further and does in fact get better.”

He noted that the fact that a number of industries are being affected could give cause for hope that there will be change. “I do think we have a collective pain here where we have got all the emerging technologies under attack,” said Stoll. “It is rare we get the folks in the software creation industry in complete alignment with those in the biotech industry. The catalytic manufacturing industry is also going be impacted as are surgical devices.”

He continued: “I think you’re going to find a very strong group of companies and interests looking to fix this. If we decide to go in that direction, that would be very helpful for moving things on the Hill, because I do believe that Members of Congress and Senators listen to their constituents who come to talk to them. Patent subject matter eligibility hasn’t been at the forefront in Congress, but as it elevates there may be some interest in doing something.”

more from across site and SHARED ros bottom lb

More from across our site

Regulatory changes and damages risks are prompting Canadian firms and clients to opt for settlements in generic and biosimilar cases
News of Via Licensing Alliance adding two new members and Nokia’s proposal to extend interim licences to Warner Bros Discovery and Paramount were also among the top talking points
A new claim filed by Ericsson, and a request for access to documents, were also among recent developments
Cooley and Stikeman Elliott advised 35Pharma on the deal, which will allow GSK to get its hands on S235, an investigational medicine for pulmonary hypertension
Simon Wright explains why the UK should embrace the possibility of rejoining the UPC, and reveals how CIPA is reacting to this month’s historic Emotional Perception AI case at the UK Supreme Court
Matthew Grady of Wolf Greenfield says AI presents an opportunity in patent practice for stronger collaboration between in-house and outside counsel
Aparna Watal, head of trademarks at Halfords IP, discusses why lawyers must take a stand when advising clients and how she balances work, motherhood and mentoring
Discussion hosted by Bird & Bird partners also hears that UK courts’ desire to determine FRAND rates could see the jurisdiction penalised in a similar way to China
The platform’s proactive intellectual property enforcement helps brands spot and kill fakes, so they can focus on growth. Managing IP learns more about the programme
Hire of José María del Valle Escalante to lead the firm’s operations in ‘dynamic’ Catalonia and Aragon regions follows last month’s appointment of a new chief information officer
Gift this article